Unity HA

Unity HA is a subsidiary incubated by Bonutti Research and is a medical device company. With over 400 patents and 700 licenses, the company is dedicated to developing and commercializing innovative therapies for treating primary cranial neuralgic disorders, particularly severe headaches. The company acquired the intellectual property of Autonomic Technologies, Inc. (ATI) and continues to advance cost-effective technologies for the prevention and treatment of cluster headaches as well as future indications for sphenopalatine ganglion neuromodulation.